HOOD insider 10b5-1 sale: 52,540 shares
HOOD reported an insider sale under a 10b5-1 plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HOOD reported an insider sale under a 10b5-1 plan. The filing shows a 10b5-1 sale of 52,540 shares of Common stock on 02/03/2026 with proceeds of $4,613,285.21. The notice also lists 8,540 Restricted Stock Units dated 03/01/2026.
Insights
Routine 10b5-1 disposition disclosed; no new operational metrics.
The filing documents a planned sale executed under a 10b5-1 arrangement: 52,540 shares sold on 02/03/2026 for $4,613,285.21. This is a disclosure of an insider liquidity event rather than a corporate financial development.
Compliance implications are limited: confirm plan timing and adherence to trading-plan terms in subsequent filings. No company proceeds are reported because this is a selling‑holder transaction.
Key Figures
Key Terms
10b5-1 plan regulatory
Form 144 regulatory
Restricted Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the HOOD Form 144 disclose about the insider sale?
Does the Form 144 indicate company proceeds to HOOD from the sale?
Who executed the sales reported in the HOOD Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.